ARK Genomic Revolution ETF Rating $32.85 -0.71 (-2.12%) As of 04:10 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartHeadlinesHoldingsOwnershipRatingsShort InterestBuy This Stock ARK Genomic Revolution ETF Aggregate Rating and Price Target (2026)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.ARKG Aggregate RatingModerate Buy 2.54Holdings in ARKG have an aggregate rating of Moderate Buy based on 304 analyst ratings issued in the past year covering 25 companies (93.8% of the portfolio).ARKG Aggregate Price Target$32.85High Prediction$32.85Average Prediction$32.85Low Prediction$32.85Holdings in ARKG have an aggregate price target of $32.85 and a range of $32.85 to $32.85 covering 25 companies (93.8% of the portfolio).ARKG Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy0 Buy rating(s)Moderate Buy15 Moderate Buy rating(s)Hold9 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by ARK Genomic Revolution ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 25 ARKG Holdings ExportWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings9.02%TWSTTwist Bioscience$67.77-3.3%2.0319 of 5 stars2.75$58.00 -14.4%87.95%CRSPCRISPR Therapeutics$49.44-4.0%3.634 of 5 stars2.53$65.47 32.4%197.69%TEMTempus AI$49.48+1.4%3.5352 of 5 stars2.47$68.64 38.7%15Trending NewsGap Down7.10%TXG10x Genomics$29.11-4.8%1.8948 of 5 stars2.20$23.17 -20.4%15News Coverage6.48%PSNLPersonalis$9.61-1.4%2.803 of 5 stars2.57$11.00 14.5%75.84%ABSIAbsci$6.38-6.6%4.0038 of 5 stars2.63$8.52 33.5%84.82%BEAMBeam Therapeutics$29.49-3.2%3.1695 of 5 stars2.71$46.83 58.8%144.41%GHGuardant Health$130.70+0.4%1.9848 of 5 stars2.95$139.80 7.0%22Analyst ForecastInsider Trade4.41%ILMNIllumina$162.47+1.5%2.2003 of 5 stars2.33$142.13 -12.5%18Positive NewsAnalyst UpgradeInsider TradeGap Up3.90%NTRANatera$216.50-2.8%3.832 of 5 stars2.81$256.12 18.3%21Insider Trade3.33%NTLAIntellia Therapeutics$12.20-5.4%3.3881 of 5 stars2.35$20.25 66.0%233.20%VCYTVeracyte$48.17-2.2%2.5532 of 5 stars2.56$47.57 -1.2%93.19%RXRXRecursion Pharmaceuticals$3.04-5.6%3.4308 of 5 stars2.20$8.10 166.4%5News CoverageGap Down2.90%CDNACareDx$23.46+3.1%1.8697 of 5 stars2.00$25.00 6.6%6News CoverageInsider Trade2.89%CMPSCompass Pathways$11.03-2.0%3.046 of 5 stars2.93$21.36 93.7%142.46%ADPTAdaptive Biotechnologies$17.07-1.7%3.4582 of 5 stars2.63$19.57 14.7%8News CoverageInsider Trade2.22%SDGRSchrodinger$14.15-2.5%3.1403 of 5 stars2.33$20.25 43.1%9Positive News1.76%NRIXNurix Therapeutics$15.30-2.2%2.6757 of 5 stars2.88$32.14 110.1%16Trending NewsAnalyst Forecast1.72%WGSGeneDx$54.32-3.6%4.5887 of 5 stars2.63$96.43 77.5%8Trending NewsInsider TradeGap Down1.70%BFLYButterfly Network$5.37+4.8%1.0482 of 5 stars2.33$5.56 3.7%6Positive NewsInsider TradeGap Down1.51%ARCTArcturus Therapeutics$6.89-3.8%2.3965 of 5 stars2.67$25.44 269.3%121.45%IONSIonis Pharmaceuticals$73.32-1.7%3.4941 of 5 stars2.90$100.90 37.6%21Positive News1.38%CERSCerus$2.56-0.8%3.7362 of 5 stars2.25$4.00 56.3%4Short Interest Decrease1.32%ATAIAtai Beckley$3.78-2.8%4.0753 of 5 stars2.91$16.00 323.3%11Positive NewsAnalyst ForecastGap Up1.19%PACBPacific Biosciences of California$1.372.5989 of 5 stars1.80$1.83 33.8%5Gap Down This page (BATS:ARKG) was last updated on 6/10/2026 by MarketBeat.com Staff. From Our PartnersOpenAI is preparing to go publicOpenAI - the company behind ChatGPT - has begun filing confidential paperwork for what could be the largest IP...InvestorPlace | SponsoredTrump Takes Emergency Action - Plus Elon Musk's New VentureElon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...Altimetry | SponsoredI was right about SpaceXJeff Brown predicted Bitcoin before it climbed as high as 52,400%, Tesla before 2,150%, and Nvidia before 32,0...Brownstone Research | SponsoredTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredYour book is insideThe "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...Profits Run | SponsoredImportant SpaceX PREDICTIONThe biggest IPO in stock market history could go live as soon as June 12th — but trading legend Jon Najarian s...Banyan Hill Publishing | SponsoredHe Called NVIDIA at $1.10 – Now He Says, “SELL”The analyst who called NVIDIA at $1.10 now says sell. According to Alexander Green, Chief Investment Strategis...The Oxford Club | SponsoredOne hidden supplier shipped 5 billion parts to SpaceXMost investors are focused on the historic $1.75 trillion SpaceX IPO expected around June 30. But there's a le...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ARK Genomic Revolution ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share ARK Genomic Revolution ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ARKG Stock Alerts